Literature DB >> 19538992

Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.

Florence Dubois1, Stéphanie Caby, Frédérik Oger, Céline Cosseau, Monique Capron, Christoph Grunau, Colette Dissous, Raymond J Pierce.   

Abstract

In order to explore the conservation/divergence of transcriptional regulation in the platyhelminth parasite Schistosoma mansoni, we are studying the structures and functions of transcriptional mediators and in particular histone-modifying enzymes. Reversible histone acetylation changes chromatin structure and modulates gene transcription. The removal of acetyl residues from histones and other proteins is catalyzed by histone deacetylases (HDACs) that are under increasing study as therapeutic targets, both in cancer and parasitic diseases. In order to determine the extent and importance of histone acetylation in S. mansoni, we tested the effects of three histone deacetylase inhibitors (HDACi) on both larval and adult worms in culture. Trichostatin A (TSA), valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) inhibited global HDAC activity at all life-cycle stages. TSA and VPA, but not SAHA, caused mortality of schistosomula and adults, with TSA showing the most rapid effect. Moreover, TSA caused an increase in apoptosis in schistosomula shown by the TUNEL assay and an increase in caspase 3/7 activity. Both TSA and VPA were shown to cause an increase in general levels of protein acetylation in schistosomes; more particularly of histone 4 whereas histone 3 acetylation was less affected. In the case of TSA treatment this histone hyperacetylation was correlated with the increased expression of caspases 3 and 7 transcripts. Finally, quantitative chromatin immunoprecipitation showed that the proximal promoter region of the S. mansoni caspase 7 gene was hyperacetylated on histone H4 after TSA treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538992     DOI: 10.1016/j.molbiopara.2009.06.001

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  36 in total

1.  Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni.

Authors:  Juliana Kelle de Andrade Lemoine Neves; Sandra Paula Sarinho Botelho; Cristiane Moutinho Lagos de Melo; Valéria Rêgo Alves Pereira; Maria do Carmo Alves de Lima; Ivan da Rocha Pitta; Mônica Camelo Pessoa de Azevedo Albuquerque; Suely Lins Galdino
Journal:  Parasitol Res       Date:  2010-05-04       Impact factor: 2.289

Review 2.  Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?

Authors:  Godwin Akpeko Dziwornu; Henrietta Dede Attram; Samuel Gachuhi; Kelly Chibale
Journal:  RSC Med Chem       Date:  2020-04-06

Review 3.  Modern approaches to accelerate discovery of new antischistosomal drugs.

Authors:  Bruno Junior Neves; Eugene Muratov; Renato Beilner Machado; Carolina Horta Andrade; Pedro Vitor Lemos Cravo
Journal:  Expert Opin Drug Discov       Date:  2016-05-03       Impact factor: 6.098

Review 4.  Toxoplasma histone acetylation remodelers as novel drug targets.

Authors:  Laura Vanagas; Victoria Jeffers; Silvina S Bogado; Maria C Dalmasso; William J Sullivan; Sergio O Angel
Journal:  Expert Rev Anti Infect Ther       Date:  2012-10       Impact factor: 5.091

5.  Schistosoma mansoni mucin gene (SmPoMuc) expression: epigenetic control to shape adaptation to a new host.

Authors:  Cecile Perrin; Julie M J Lepesant; Emmanuel Roger; David Duval; Sara Fneich; Virginie Thuillier; Jean-Francois Alliene; Guillaume Mitta; Christoph Grunau; Celine Cosseau
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

6.  Cell death and reproductive regression in female Schistosoma mansoni.

Authors:  Sarah E Galanti; Stanley Ching-Cheng Huang; Edward J Pearce
Journal:  PLoS Negl Trop Dis       Date:  2012-02-21

7.  Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.

Authors:  Jessica A Engel; Amy J Jones; Vicky M Avery; Subathdrage D M Sumanadasa; Susanna S Ng; David P Fairlie; Tina Skinner-Adams; Katherine T Andrews
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-06-20       Impact factor: 4.077

8.  Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats.

Authors:  Chieh-Hsin Wu; Yi-Cheng Tsai; Tai-Hsin Tsai; Keng-Liang Kuo; Yu-Feng Su; Chih-Hui Chang; Chih-Lung Lin
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.

Authors:  Martin Marek; Srinivasaraghavan Kannan; Alexander-Thomas Hauser; Marina Moraes Mourão; Stéphanie Caby; Vincent Cura; Diana A Stolfa; Karin Schmidtkunz; Julien Lancelot; Luiza Andrade; Jean-Paul Renaud; Guilherme Oliveira; Wolfgang Sippl; Manfred Jung; Jean Cavarelli; Raymond J Pierce; Christophe Romier
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

10.  Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets.

Authors:  Julien Lancelot; Stéphanie Caby; Florence Dubois-Abdesselem; Mathieu Vanderstraete; Jacques Trolet; Guilherme Oliveira; Franz Bracher; Manfred Jung; Raymond J Pierce
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.